REGULATORYRFK Jr.: 14 peptides returning to Category 1 — FDA advisory committee July 2026TRENDINGHexarelin: ↑↑ Surging ��� Trends score 100 as of May 2026UPDATESemaglutide and tirzepatide compounding ended — shortage resolved Feb/May 2025REGULATORYBPC-157, TB-500, thymosin alpha-1, CJC-1295, ipamorelin: expected Category 1 reclassification pendingEVENTpep-talk con ��� First US Peptide Convention · August 2026 · Anaheim CAFDAFDA advisory committee meetings scheduled: late July 2026REGULATORYRFK Jr.: 14 peptides returning to Category 1 — FDA advisory committee July 2026TRENDINGHexarelin: ↑↑ Surging ��� Trends score 100 as of May 2026UPDATESemaglutide and tirzepatide compounding ended — shortage resolved Feb/May 2025REGULATORYBPC-157, TB-500, thymosin alpha-1, CJC-1295, ipamorelin: expected Category 1 reclassification pendingEVENTpep-talk con ��� First US Peptide Convention · August 2026 · Anaheim CAFDAFDA advisory committee meetings scheduled: late July 2026

For research purposes only. Full disclaimer →

Peptide Library

Lemon Bottle

Lemon Bottle Fat Dissolve

Weight Loss & Metabolic

Lemon Bottle is a branded lipolytic injection solution that is not a peptide but rather a combination of riboflavin (vitamin B2), bromelain (pineapple-derived enzyme), and lecithin, marketed primarily in the aesthetic medicine market for non-surgical fat dissolution. Originating from South Korea, it has gained rapid popularity in cosmetic clinics worldwide as an alternative to traditional deoxycholic acid-based fat dissolving injections. The product claims to induce adipocyte lipolysis and fat cell destruction through its combined enzymatic and emulsifying components.

Mechanism of Action

Injectable fat-dissolving solution containing riboflavin, lecithin, and bromelain. Disrupts adipocyte cell membranes.

Research Protocols

For research purposes only. Not medical advice.

Administered by trained practitioners. 2-5ml per treatment area, injected subcutaneously. Treatments spaced 2-4 weeks apart.

Research Notes

Clinical Research Status

Lemon Bottle has not undergone rigorous peer-reviewed clinical trials or regulatory approval by the FDA, EMA, or other major pharmaceutical regulatory bodies for fat dissolution. The product is marketed as a "lipolytic solution" rather than a pharmaceutical, allowing it to be sold in many jurisdictions without the clinical trial data required for drug approval. Anecdotal clinical results from aesthetic practitioners are widely shared on social media and at industry conferences, but independent verification of efficacy claims remains lacking.

Key Published Findings

No peer-reviewed publications in indexed medical journals have specifically evaluated Lemon Bottle's efficacy or mechanism of action as a combined formulation. Individual components have established biochemistry: bromelain has proteolytic and anti-inflammatory properties, lecithin (phosphatidylcholine) has been studied for injection lipolysis, and riboflavin participates in fatty acid oxidation. However, the specific concentrations, combination ratios, and delivery method used in Lemon Bottle have not been independently validated for fat reduction.

Safety Profile

Reports of adverse effects include significant swelling, bruising, pain at injection sites, skin necrosis in rare cases, and irregular contour deformities when administered improperly. Without standardized clinical trials, the true incidence of complications is unknown and likely underreported in the commercial aesthetic setting. Concerns have been raised by medical professionals regarding the lack of long-term safety data, unknown product consistency between batches, and potential risks of injecting enzymatic compounds into subcutaneous tissue.

Comparison to Related Compounds

Unlike Kybella (deoxycholic acid), which is FDA-approved specifically for submental fat and has completed rigorous Phase III clinical trials, Lemon Bottle has no regulatory approval for any fat reduction indication. Compared to traditional phosphatidylcholine/deoxycholate (PCDC) injection lipolysis, Lemon Bottle claims to produce less swelling and downtime, though this has not been verified in comparative studies. The bromelain component distinguishes it from other lipolytic injectables, theoretically providing enzymatic fat breakdown, but optimal concentrations for subcutaneous injection have not been established.

Community Observations

The aesthetic community is divided on Lemon Bottle, with some practitioners reporting impressive results in small treatment areas while others express concern about the lack of regulatory oversight and clinical evidence. Social media has amplified its popularity, particularly on TikTok and Instagram, leading to widespread use despite medical community reservations. Price points are significantly lower than FDA-approved alternatives, contributing to its market adoption but also raising questions about product quality and manufacturing standards.

Half-Life

N/A (not a peptide)

Reconstitution

Pre-mixed solution (no reconstitution)

Storage

Lyophilized

Refrigerate 2-8C.

Reconstituted

Use immediately after opening.

US Legal Status

Unregulated cosmetic product

Also Known As

Lemon Bottle Fat Dissolve

PeptideVault provides research-based summaries for informational purposes only. We do not host, distribute, or endorse vendor documentation. All certificates of analysis, GMP certificates, and vendor communications must be requested and verified directly by the buyer. Nothing on this platform constitutes legal, medical, or professional advice. Users are solely responsible for verifying vendor credentials and ensuring compliance with all applicable local, state, and federal laws before purchasing any research chemicals. Use of this platform constitutes acceptance of full personal responsibility.

Read full disclaimer